Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Acer Therapeutics
Acer Therapeutics
(ACER)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Olpruva
Phenylbutyric acid
2022-12-22
Ornithine carbamoyltransferase deficiency disease
,
Carbamoyl-phosphate synthase i deficiency disease
,
Citrullinemia
,
Amyotrophic lateral sclerosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Phenylbutyric acid
multiple acyl coenzyme a dehydrogenase deficiency
Celiprolol
postoperative complications
,
cardiac arrhythmias
,
ehlers-danlos syndrome
,
type iv ehlers-danlos syndrome
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
syndrome
,
williams syndrome
Bevifimod
congenital hyperinsulinism
,
glucose metabolism disorders
,
diabetes mellitus
,
hypothyroidism
,
type 1 diabetes mellitus
,
hypoglycemia
Zotiraciclib
multiple myeloma
,
blast crisis
,
colorectal neoplasms
,
rectal neoplasms
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
lymphoma
,
b-cell chronic lymphocytic leukemia
,
melanoma
,
syndrome
,
leukemia
,
neoplasms
,
fallopian tube neoplasms
,
ovarian epithelial carcinoma
,
glioblastoma
,
astrocytoma
,
brain neoplasms
,
myelodysplastic syndromes
,
precursor cell lymphoblastic leukemia-lymphoma
,
bcr-abl positive chronic myelogenous leukemia
,
myeloid leukemia
,
preleukemia
,
lymphoid leukemia
,
recurrence
,
malaria
,
falciparum malaria
,
glioma
,
neoplasm metastasis
,
ovarian neoplasms
,
peritoneal neoplasms
,
gliosarcoma
,
myeloid leukemia acute
,
non-hodgkin lymphoma
,
lymphoproliferative disorders
,
hemophagocytic lymphohistiocytosis
,
hematologic neoplasms
,
biphenotypic leukemia acute
,
refractory anemia with excess of blasts
,
multiple sclerosis
,
disease progression
,
autoimmune diseases
,
nervous system diseases
,
autoimmune diseases of the nervous system
,
chronic progressive multiple sclerosis
,
sclerosis
,
fibrosis
,
idiopathic pulmonary fibrosis
,
pulmonary fibrosis
,
type 2 diabetes mellitus
,
coronary artery disease
,
burns
,
chronic obstructive pulmonary disease
,
polycystic ovary syndrome
,
oligomenorrhea
,
diabetes mellitus
,
hyperglycemia
,
knee osteoarthritis
,
osteoarthritis
,
breast neoplasms
,
capillary fragility
,
wounds and injuries
,
respiratory aspiration
,
inhalation
,
tooth wear
,
tooth attrition
,
obsessive-compulsive disorder
,
compulsive personality disorder
,
hypersensitivity
,
milk hypersensitivity
,
anorexia
,
anorexia nervosa
,
obesity
,
weight loss
,
alzheimer disease
,
hand injuries
,
chronic renal insufficiency
,
kidney diseases
,
neck pain
,
lung diseases
,
obstructive lung diseases
,
sickle cell anemia
,
cerebral palsy
,
neuralgia
,
postherpetic neuralgia
,
schizophrenia
,
cognitive dysfunction
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use